Correction: Billeaud et al. "Effects on Fatty Acid Metabolism of a New Powdered Human Milk Fortifier Containing Medium-Chain Triacylglycerols and Docosahexaenoic Acid in Preterm Infants" Nutrients 2018, 10, 690

Affiliations

¹ CIC Pédiatrique 1401 CHU, 33000 Bordeaux, France. claude.billeaud@chu-bordeaux.fr.
² ITERG, Université de Bordeaux, 33076 Bordeaux, France. c.vaysse@iterg.com.
³ ITERG, Université de Bordeaux, 33076 Bordeaux, France. l.couedelo@iterg.com.
⁴ Nestlé Health Sciences, 1066 Epalinges, Switzerland. philippe.steenhout@nestle.com.
⁵ Nestlé Research Centre, 1000 Lausanne, Switzerland. jnthn.jaeger@gmail.com.
⁶ Nestlé Research Centre, 1000 Lausanne, Switzerland. cristina.cruz-hernandez@rdls.nestle.com.
⁷ Nestlé Nutrition R&D, 1800 Vevey, Switzerland. laurent.ameye@nestle.com.
⁸ Department of Neonatology, University of Liège, 4000 Liège, Belgium. j.rigo@ulg.ac.be.
⁹ Hôpital de la Croix Rousse, Hospices Civils, 69004 Lyon, France. jean-charles.picaud@chu-lyon.fr.
¹⁰ Hôpital Clocheville, CHU de Tours, 37004 Tours, France. elie.saliba@univ-tours.fr.
¹¹ Nestlé Nutrition R&D, 1800 Vevey, Switzerland. nicholaspaul.hays@nestle.com.
¹² Nestlé Nutrition R&D, 1800 Vevey, Switzerland. frederic.destaillats@nestle.com.

Published Erratum

Claude Billeaud et al. Nutrients. 2019.

. 2019 Mar 22;11(3):680.

doi: 10.3390/nu11030680.

¹ CIC Pédiatrique 1401 CHU, 33000 Bordeaux, France. claude.billeaud@chu-bordeaux.fr.
² ITERG, Université de Bordeaux, 33076 Bordeaux, France. c.vaysse@iterg.com.
³ ITERG, Université de Bordeaux, 33076 Bordeaux, France. l.couedelo@iterg.com.
⁴ Nestlé Health Sciences, 1066 Epalinges, Switzerland. philippe.steenhout@nestle.com.
⁵ Nestlé Research Centre, 1000 Lausanne, Switzerland. jnthn.jaeger@gmail.com.
⁶ Nestlé Research Centre, 1000 Lausanne, Switzerland. cristina.cruz-hernandez@rdls.nestle.com.
⁷ Nestlé Nutrition R&D, 1800 Vevey, Switzerland. laurent.ameye@nestle.com.
⁸ Department of Neonatology, University of Liège, 4000 Liège, Belgium. j.rigo@ulg.ac.be.
⁹ Hôpital de la Croix Rousse, Hospices Civils, 69004 Lyon, France. jean-charles.picaud@chu-lyon.fr.
¹⁰ Hôpital Clocheville, CHU de Tours, 37004 Tours, France. elie.saliba@univ-tours.fr.
¹¹ Nestlé Nutrition R&D, 1800 Vevey, Switzerland. nicholaspaul.hays@nestle.com.
¹² Nestlé Nutrition R&D, 1800 Vevey, Switzerland. frederic.destaillats@nestle.com.

Abstract

The authors wish to make a correction to the published version of their paper [...].

Effects on Fatty Acid Metabolism of a New Powdered Human Milk Fortifier Containing Medium-Chain Triacylglycerols and Docosahexaenoic Acid in Preterm Infants.
Billeaud C, Boué-Vaysse C, Couëdelo L, Steenhout P, Jaeger J, Cruz-Hernandez C, Ameye L, Rigo J, Picaud JC, Saliba E, Hays NP, Destaillats F. Billeaud C, et al. Nutrients. 2018 May 29;10(6):690. doi: 10.3390/nu10060690. Nutrients. 2018. PMID: 29843467 Free PMC article. Clinical Trial.

1. Billeaud C., Boué-Vaysse C., Couëdelo L., Steenhout P., Jaeger J., Cruz-Hernandez C., Ameye L., Rigo J., Picaud J.C., Saliba E., et al. Effects on fatty acid metabolism of a new powdered human milk fortifier containing medium-chain triacylglycerols and docosahexaenoic acid in preterm infants. Nutrients. 2018;10:690. doi: 10.3390/nu10060690. - DOI - PMC - PubMed
1. Bernhard W., Poets C.F., Franz A.R. Letter to the Editor Re: Billeaud et al. Nutrients 2018, 10, 690. Nutrients. 2019;11:103. doi: 10.3390/nu11010103. - DOI - PMC - PubMed